$134.03
▲ +0.9% Today
as of Jul 22, 10:15 ET
Last 30 days
Recent Press Releases & News
lean bull
▲ 4
● 21
▼ 0
Agilent Increases Its Investment in HALO X-ray Technologies
A: Raising target price to $149.00
Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers
Overview
52-week range
$108
$160
49% of range
Avg surprise (last 3)
+3.7%
Avg reaction (last 2)
+0.2%
50% positive
Latest IV / EM
33%
EM ±7.7% · $135 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 27, 2026 | Apr/2026 | $1.49 | $1.40 | +6.4% | +13.7% | +0.7% | earnings |
| Sat Jan 31, 2026 | Jan 2026 | $1.07 | — | — | — | — | financials |
| Wed Aug 27, 2025 | Jul/2025 | $1.37 | $1.36 | +0.7% | — | — | earnings |
| Wed May 28, 2025 | Apr/2025 | $1.31 | $1.26 | +4.0% | — | -0.3% | earnings |
| Fri Jan 31, 2025 | Jan 2025 | $1.11 | — | — | — | — | financials |
| Wed Jul 31, 2024 | Jul 2024 | $0.97 | — | — | — | — | financials |
| Tue Apr 30, 2024 | Apr 2024 | $1.05 | — | — | — | — | financials |
| Wed Jan 31, 2024 | Jan 2024 | $1.18 | — | — | — | — | financials |
| Mon Jul 31, 2023 | Jul 2023 | $0.38 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $399M | $353M | — | $360M | $300M | $376M | — | $333M |
| Net income | $339M | $305M | — | $336M | $215M | $318M | — | $282M |
| EPS (diluted) | $1.20 | $1.07 | — | $1.18 | $0.75 | $1.11 | — | $0.97 |
Balance sheet (quarterly)
| Metric | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B |
| Inventory | $1.09B | $1.06B | $1.02B | $1.01B | $991M | $997M | $972M | $978M |
| Total current assets | $4.76B | $4.62B | $4.59B | $4.25B | $4.21B | $4.11B | $3.96B | $4.26B |
| Total assets | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B |
| Total equity | $7.12B | $6.91B | $6.74B | $6.37B | $6.14B | $6.03B | $5.90B | $5.90B |